Background: Anxiety disorder is one of the most common mental disorders and often accompanied with sleep disturbance which can in turn exacerbate anxiety symptoms, creating a vicious cycle. In addition to psychopharmacological therapy, the effectiveness of psychotherapy as cognitive behavioral therapy (CBT) for treating anxiety disorders and insomnia has been well documented and widely accepted, but it is labor‐intensive and costly. However, virtual reality (VR)–integrated CBT may improve this condition but needs more evidences to support its extensive application in routine clinical practice.Objectives: This explorative study was aimed to conduct a retrospective analysis to evaluate the acute (2 weeks) augmented effect of VR‐integrated relaxation and mindfulness exercising in improving anxiety and insomnia symptoms for patients who were diagnosed with anxiety disorders and concurrently with prominent insomnia symptoms and admitted to the Department of Psychiatry, The Affiliated Guangdong Second Provincial General Hospital of Jinan University during January 2021 to June 2021.Methods: All patients who were admitted to the department of psychiatry during January 1, 2021 to June 30, 2021 were screened with inclusion criteria and exclusion criteria, and the sociodemographic and clinical data of those included patients were collected from the electronic medical record system of the hospital using a self‐designed case report form (CRF). Subjects who were administrated with medication alone were designated as conventional group, and those receiving treatment of medication combined with VR‐integrated CBT (VR relaxation and mindfulness exercising) as VR group. The baseline and 2‐week posttreatment data were compared between the two groups.Results: In total, there were 103 patients (70 female, 68%) included in the study. Among all, 68 (66.02%) were designated as the “VR group,” and 35 (33.98%) as the “conventional group.” The majority of patients (67%) were diagnosed with generalized anxiety disorder (GAD). Twenty‐three (22.3%) patients had a comorbid diagnosis with primary insomnia, and insomnia was just one of the accompanying symptoms with anxiety for the rest 80 subjects. No statistically significant differences were found between VR and conventional groups in all baseline sociodemographic and clinical characteristics except for occupation. There were statistically significant differences for the remission rates of anxiety symptoms or insomnia symptoms and reduction of Hamilton Anxiety Rating Scale or Insomnia Severity Index total scores between conventional and VR groups. Greater remission rates or score reductions were found in VR group than in conventional group either for anxiety or for insomnia. Robust differences still existed when controlled for the variable “occupation.”Conclusions: Two‐week augmented VR‐integrated relaxation and mindfulness exercising is acutely beneficial for relieving both anxiety and insomnia symptoms and worth being recommended for routine clinical practice. Further prospective and randomized study compared to traditional CBT to explore its acute and long‐term effect on anxiety and insomnia is needed.
Major depressive disorder (MDD) is a prevalent psychiatric condition often accompanied by severe impairments in cognitive and functional capacities. This research was conducted to identify RNA modification-related gene signatures and associated functional pathways in MDD. Differentially expressed RNA modification-related genes in MDD were first identified. And a random forest model was developed and distinct RNA modification patterns were discerned based on signature genes. Then, comprehensive analyses of RNA modification-associated genes in MDD were performed, including functional analyses and immune cell infiltration. The study identified 29 differentially expressed RNA modification-related genes in MDD and two distinct RNA modification patterns. TRMT112, MBD3, NUDT21, and IGF2BP1 of the risk signature were detected. Functional analyses confirmed the involvement of RNA modification in pathways like phosphatidylinositol 3-kinase signaling and nucleotide oligomerization domain (NOD)-like receptor signaling in MDD. NUDT21 displayed a strong positive correlation with type 2 T helper cells, while IGF2BP1 negatively correlated with activated CD8 T cells, central memory CD4 T cells, and natural killer T cells. In summary, further research into the roles of NUDT21 and IGF2BP1 would be valuable for understanding MDD prognosis. The identified RNA modification-related gene signatures and pathways provide insights into MDD molecular etiology and potential diagnostic biomarkers.
Background: This study investigated the depression, anxiety, and insomnia levels of coronavirus disease 2019 (COVID-19) patients admitted to two mobile cabin hospitals in Jianghan District (Wuhan, China). Methods: Thirty COVID-19 (eight mild type and twenty-two common type) patients were evaluated using the Patient Health Questionnaire-9, the Generalized Anxiety Disorder 7 Questionnaire, the Insomnia Severity Index, and a semi-structured interview. Results: All 30 patients reported varying degrees of anxiety, depression, and insomnia. The levels of depression and anxiety in mild type COVID-19 patients were significantly lower than those in common type COVID-19 patients. Significant improvements in depression (P<0.001) and anxiety (P<0.001) levels were found in the COVID-19 patients at the second evaluation compared with the baseline (admittance to hospital). More than 80% patients agreed that medical security, support from other patients, and a better living environment were the main reasons for improvements to their adverse psychological states. Conclusions: Varying degrees of anxiety, depression, and insomnia frequently occur in patients with COVID-19. Standard treatment protocols and patient-centered care in the mobile cabin hospitals in this study provided the chance for COVID-19 patients to successfully improve their mental health during the outbreak of the pandemic.
21 July 2025 in IEEE Transactions on Mobile Computing
Depression significantly impacts mental health, severely disrupting patients’ daily lives. During depressive episodes, individuals may experience symptoms such as excessive guilt, self-harm, and suicidal ideation. Compared to proprietary devices like brain electrode caps, wearable technologies for depression detection have gained attention due to their affordability and portability—enabling real-time monitoring of depressive states. However, challenges such as low-quality data from ubiquitous devices, individual variability, and the complexity of multimodal physiological signal analysis limit model generalizability. To address these issues, we present DepGuard, a novel ubiquitous wearable system for depression assessment based on multimodal physiological signals. DepGuard performs a two-stage detection process: depression recognition and real-time episode monitoring. For depression recognition, we propose an unsupervised domain adaptation method to reduce the domain gap between source and target subjects. For episode monitoring, we employ a few-shot learning strategy to enable personalized modeling. Both approaches enhance cross-subject generalization. Our system achieves 90.75% accuracy in cross-subject depression recognition using 30 unlabeled samples per target subject, and 93.52% accuracy in episode monitoring using 15 labeled samples per class.
Objective: Non‐suicidal self‐injury (NSSI) frequently co‐occurs with childhood trauma (CT) and depression; however, their interplay and underlying mechanisms are not fully understood. This article explores the nuanced relationships between these factors and their impact on NSSI, offering practical insights for the prevention and intervention of childhood post‐traumatic depression progression and NSSI among adolescents.Methods: The present study leveraged the Childhood Trauma Questionnaire (CTQ), the Adolescent Non‐suicidal Self‐injury Assessment Questionnaire (ANSAQ), and the Hamilton Rating Scale for Depression (HAMD) to assess a cohort of 361 individuals with mood disorders. The study design was cross‐sectional, and a convenience sampling method was utilized. The mediation effect was tested using the Process stepwise regression method, and the significance of the mediation effect was assessed through Bootstrap analysis.Results: Among 361 adolescents with mood disorders, 232 (64.3%) exhibited NSSI behaviors. Analyses revealed that CT was directly associated with NSSI (β = 0.312, p < 0.001) and indirectly associated through mediation pathways (β = 0.256, p < 0.001). CT also showed direct association with depression severity (β = 0.400, p < 0.001). Depression severity was significantly associated with NSSI (β = 0.184, p = 0.042), suggesting a partial mediating role of depression severity in this relationship.Conclusions: CT shows a significant association with NSSI among adolescents with mood disorders, with depression severity serving as a partial mediator in this relationship. Active coping strategies targeting depressive symptoms in individuals with a history of CT may help reduce NSSI behaviors.
Machine learning (ML) has been widely used to predict suicidal attempts (SA) in adolescents and adults. However, there is a need for studies of accurate and efficient SA models specifically for use in adolescents with mood disorders due to a lack of existing research integrating risk variables when predicting clinical SA. As such, this study aimed to explore the potential of ML models to predict SA among adolescents with mood disorders. Study participants were 134 Chinese adolescents with mood disorders (20.1% boys, Mage = 15.26, SD = 1.67) and their treating physicians. Of these adolescents, 53 had clinically documented SA. Four ML models – logistic regression (LR), random forest (RF), eXtreme gradient boosting machine (XGBM), and light gradient boosting machine (LGBM) were used to predict SA in participants, and their results were compared to identify key predictive variables as well as the best-performing model. Class imbalance was handled via Synthetic Minority Oversampling Technique applied only to each training fold, and every model was tuned and evaluated with stratified 10-fold cross-validation. The LGBM model achieved the highest discriminant performance, with an AUC of 0.79 and an accuracy of 0.75, with factors of the emotional expression functioning of non-suicidal self-injury, suicidal planning, peer relationship issues, physician-assessed depression levels, and patient self-reported anxiety and depression levels all demonstrating the highest values in predicting SA. The findings of this study indicate that the LGBM model, which uses adolescents’ clinical characteristics and experiences, was the most effective in estimating SA in adolescents with mood disorders. Future research should validate this model further in other populations, as well as assess its utility in selecting suicide prevention interventions. The online version contains supplementary material available at 10.1186/s12888-025-07145-z.